|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/574 | |
| A61K 38/15 | |||
| G01N 33/68 |
| (11) | Number of the document | 2893350 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13767166.5 |
| Date of filing the European patent application | 2013-09-06 | |
| (97) | Date of publication of the European application | 2015-07-15 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/058379 |
| Date | 2013-09-06 |
| (87) | Number | WO 2014/039744 |
| Date | 2014-03-13 |
| (30) | Number | Date | Country code |
| 201261698341 P | 2012-09-07 | US | |
| 201261726464 P | 2012-11-14 | US | |
| 201361784501 P | 2013-03-14 | US |
| (72) |
TROWE, Torsten, Bernhard, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | RESISTANCE BIOMARKERS FOR HDAC INHIBITORS |
| RESISTANCE BIOMARKERS FOR HDAC INHIBITORS |